<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25142603</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>88</Volume><Issue>21</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71.</ArticleTitle><Pagination><StartPage>12485</StartPage><EndPage>12499</EndPage><MedlinePgn>12485-99</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00692-14</ELocationID><Abstract><AbstractText Label="UNLABELLED">Like poliovirus infection, severe infection with enterovirus 71 (EV71) can cause neuropathology. Unlike poliovirus, EV71 is often associated with hand-foot-and-mouth disease (HFMD). Here we established three mouse models for experimental infection with the same clinical isolate of EV71. The NOD/SCID mouse model is unique for the development of skin rash, an HFMD-like symptom. While the NOD/SCID mice developed limb paralysis and death at near-100% efficiency, the gamma interferon receptor knockout (ifngr KO) and stat-1 knockout mice exhibited paralysis and death rates near 78% and 30%, respectively. Productive infection with EV71 depends on the viral dose, host age, and inoculation route. Levels of infectious EV71, and levels of VP1-specific RNA and protein in muscle, brain, and spinal cord, were compared side by side between the NOD/SCID and stat-1 knockout models before, during, and after disease onset. Spleen fibrosis and muscle degeneration are common in the NOD/SCID and stat-1 knockout models. The main differences between these two models include their disease manifestations and cytokine/chemokine profiles. The pathology of the NOD/SCID model includes (i) inflammation and expression of viral VP1 antigen in muscle, (ii) increased neutrophil levels and decreased eosinophil and lymphocyte levels, and (iii) hair loss and skin rash. The characteristic pathology of the stat-1 knockout model includes (i) a strong tropism of EV71 for the central nervous system, (ii) detection of VP1 protein in the Purkinje layer of cerebellar cortex, pons, brain stem, and spinal cord, (iii) amplification of microglial cells, and (iv) dystrophy of intestinal villi. Our comparative studies on these new models with oral or intraperitoneal (i.p.) infection underscored the contribution of host immunity, including the gamma interferon receptor, to EV71 pathogenesis.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">In the past decade, enterovirus 71 (EV71) has emerged as a major threat to public health in the Asia-Pacific region. Disease manifestations include subclinical infection, common-cold-like syndromes, hand-foot-and-mouth disease (HFMD), uncomplicated brain stem encephalitis, severe dysregulation of the autonomic nerve system, fatal pulmonary edema, and cardiopulmonary collapse. To date, no effective vaccine or treatment is available. A user-friendly and widely accessible animal model for researching EV71 infection and pathogenesis is urgently needed by the global community, both in academia and in industry.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014, American Society for Microbiology. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Chun-Che</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liou</LastName><ForeName>An-Ting</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan Taiwan International Graduate Program (TIGP) in Molecular Medicine, National Yang-Ming University and Academia Sinica, Taipei, Taiwan Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Ya-Shu</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Szu-Yao</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Shin</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chien-Kuo</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Institute of Immunology, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kung</LastName><ForeName>John T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Pang-Hsien</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Ya-Yen</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Section of Clinical Virology and Molecular Diagnosis, Department of Laboratory Medicine, Changhua Christian Hospital, Changhua, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chi-Yung</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Section of Clinical Virology and Molecular Diagnosis, Department of Laboratory Medicine, Changhua Christian Hospital, Changhua, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jen-Shiou</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Section of Clinical Virology and Molecular Diagnosis, Department of Laboratory Medicine, Changhua Christian Hospital, Changhua, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Chiaho</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan Taiwan International Graduate Program (TIGP) in Molecular Medicine, National Yang-Ming University and Academia Sinica, Taipei, Taiwan cshih@ibms.sinica.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016513" MajorTopicYN="N">Mice, SCID</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25142603</ArticleId><ArticleId IdType="pmc">PMC4248922</ArticleId><ArticleId IdType="doi">10.1128/JVI.00692-14</ArticleId><ArticleId IdType="pii">JVI.00692-14</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 341:929&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. 2010. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 9:1097&#x2013;1105. 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Racaniello VR. 2007. Picornaviridae: the viruses and their replication, p 796&#x2013;839 In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. (ed), Fields virology, 5th ed. Lippincott Williams &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Feng Z, Hensley L, McKnight KL, Hu F, Madden V, Ping L, Jeong SH, Walker C, Lanford RE, Lemon SM. 2013. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496:367&#x2013;371. 10.1038/nature12029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12029</ArticleId><ArticleId IdType="pmc">PMC3631468</ArticleId><ArticleId IdType="pubmed">23542590</ArticleId></ArticleIdList></Reference><Reference><Citation>Sean P, Semler BL. 2008. Coxsackievirus B RNA replication: lessons from poliovirus. Curr. Top. Microbiol. Immunol. 323:89&#x2013;121. 10.1007/978-3-540-75546-3_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-75546-3_5</ArticleId><ArticleId IdType="pubmed">18357767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Chang LY. 2010. Development of enterovirus 71 vaccines. Expert Rev. Vaccines 9:149&#x2013;156. 10.1586/erv.09.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erv.09.152</ArticleId><ArticleId IdType="pubmed">20109026</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Tseng FC, Wang JR, Chi CY, Chong P, Su IJ. 2012. Challenges to licensure of enterovirus 71 vaccines. PLoS Negl. Trop. Dis. 6:e1737. 10.1371/journal.pntd.0001737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001737</ArticleId><ArticleId IdType="pmc">PMC3429393</ArticleId><ArticleId IdType="pubmed">22953003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78:7916&#x2013;7924. 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZH, Li CM, Ling P, Shen FH, Chen SH, Liu CC, Yu CK. 2008. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J. Infect. Dis. 197:854&#x2013;857. 10.1086/527326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/527326</ArticleId><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Ami Y, Wakita T, Shimizu H. 2008. Cooperative effect of the attenuation determinants derived from poliovirus Sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J. Virol. 82:1787&#x2013;1797. 10.1128/JVI.01798-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto I, Hagiwara A, Kodama H. 1978. Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease. Arch. Virol. 56:257&#x2013;261. 10.1007/BF01317855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317855</ArticleId><ArticleId IdType="pubmed">205198</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JK, Chow VT, Alonso S. 2012. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J. Virol. 86:2121&#x2013;2131. 10.1128/JVI.06103-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Partidos CD, Santangelo JD, Osorio JE. 2013. Adaptation of enterovirus 71 to adult interferon deficient mice. PLoS One 8:e59501. 10.1371/journal.pone.0059501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059501</ArticleId><ArticleId IdType="pmc">PMC3602422</ArticleId><ArticleId IdType="pubmed">23527208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15:798&#x2013;801. 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 15:794&#x2013;797. 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, Shimanuki M, Shitara H, Taya C, Koike S. 2013. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc. Natl. Acad. Sci. U. S. A. 110:14753&#x2013;14758. 10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Yu SL, Shao HY, Lin HY, Liu CC, Hsiao KN, Chitra E, Tsou YL, Chang HW, Sia C, Chong P, Chow YH. 2013. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One 8:e57591. 10.1371/journal.pone.0057591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057591</ArticleId><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang MC, Wang SM, Hsu YW, Lin HC, Chi CY, Liu CC. 2006. Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children. Pediatrics 118:e1785&#x2013;e1788. 10.1542/peds.2006-1547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-1547</ArticleId><ArticleId IdType="pubmed">17116698</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen LR, Brault AC, Nasci RS. 2013. West Nile virus: review of the literature. JAMA 310:308&#x2013;315. 10.1001/jama.2013.8042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.8042</ArticleId><ArticleId IdType="pmc">PMC4563989</ArticleId><ArticleId IdType="pubmed">23860989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zompi S, Harris E. 2012. Animal models of dengue virus infection. Viruses 4:62&#x2013;82. 10.3390/v4010062.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4010062</ArticleId><ArticleId IdType="pmc">PMC3280519</ArticleId><ArticleId IdType="pubmed">22355452</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.</Citation></Reference><Reference><Citation>Stark GR, Darnell JE., Jr 2012. The JAK-STAT pathway at twenty. Immunity 36:503&#x2013;514. 10.1016/j.immuni.2012.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.03.013</ArticleId><ArticleId IdType="pmc">PMC3909993</ArticleId><ArticleId IdType="pubmed">22520844</ArticleId></ArticleIdList></Reference><Reference><Citation>Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154:180&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">7995938</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega-Avelaira D, Ballesteros JJ, Lopez-Garcia JA. 2013. Inflammation-induced hyperalgesia and spinal microglia reactivity in neonatal rats. Eur. J. Pain 17:1180&#x2013;1188. 10.1002/j.1532-2149.2013.00308.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1532-2149.2013.00308.x</ArticleId><ArticleId IdType="pubmed">23553993</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Chen LL, Huang PN, Shih SR. 2010. Neural pathogenesis of enterovirus 71 infection. Microbes Infect. 12:505&#x2013;510. 10.1016/j.micinf.2010.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2010.03.006</ArticleId><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Yu CK, Wang JR, Su IJ, Liu CC. 2008. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J. Infect. Dis. 198:1002&#x2013;1006. 10.1086/591462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591462</ArticleId><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen FH, Tsai CC, Wang LC, Chang KC, Tung YY, Su IJ, Chen SH. 2013. Enterovirus 71 infection increases expression of interferon-gamma-inducible protein 10 which protects mice by reducing viral burden in multiple tissues. J. Gen. Virol. 94:1019&#x2013;1027. 10.1099/vir.0.046383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.046383-0</ArticleId><ArticleId IdType="pubmed">23288420</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin JE, Hackenmiller R, Simon MC, Levy DE. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443&#x2013;450. 10.1016/S0092-8674(00)81289-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81289-1</ArticleId><ArticleId IdType="pubmed">8608598</ArticleId></ArticleIdList></Reference><Reference><Citation>Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431&#x2013;442. 10.1016/S0092-8674(00)81288-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81288-X</ArticleId><ArticleId IdType="pubmed">8608597</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742&#x2013;1745. 10.1126/science.8456301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8456301</ArticleId><ArticleId IdType="pubmed">8456301</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. 2011. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J. Virol. 85:4937&#x2013;4946. 10.1128/JVI.02358-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, Lim WL, Ong BB, Paul G, AbuBakar S, Lambert M. 1998. Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133:795&#x2013;798. 10.1016/S0022-3476(98)70155-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(98)70155-6</ArticleId><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindarov LM, Chumakov MP, Voroshilova MK, Bojinov S, Vasilenko SM, Iordanov I, Kirov ID, Kamenov E, Leshchinskaya EV, Mitov G, Robinson IA, Sivchev S, Staikov S. 1979. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 23:284&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">231067</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC. 2004. A murine oral enterovirus 71 infection model with central nervous system involvement. J. Gen. Virol. 85:69&#x2013;77. 10.1099/vir.0.19423-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19423-0</ArticleId><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Badmanathan M, Devi S, Leong KL, Cardosa MJ, Wong KT. 2008. Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J. Neuropathol. Exp. Neurol. 67:532&#x2013;542. 10.1097/NEN.0b013e31817713e7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31817713e7</ArticleId><ArticleId IdType="pubmed">18520772</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, Iwasaki T, Ami Y, Tano Y, Harashima A, Suzaki Y, Sato Y, Hasegawa H, Sata T, Miyamura T, Shimizu H. 2004. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 85:2981&#x2013;2989. 10.1099/vir.0.79883-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79883-0</ArticleId><ArticleId IdType="pubmed">15448361</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng G-Z, Li M-Q, Li Y-Q, Wang X-M, Chen Q-Y, Wei H-S. 2011. Severe hand-foot-mouth disease: a report of 3 autopsied cases. Chin. J. Clin. Exp. Pathol. 27:48&#x2013;51, 55.</Citation></Reference><Reference><Citation>Khong WX, Foo DG, Trasti SL, Tan EL, Alonso S. 2011. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J. Virol. 85:3067&#x2013;3076. 10.1128/JVI.01779-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01779-10</ArticleId><ArticleId IdType="pmc">PMC3067852</ArticleId><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CS, Yao YC, Lin SC, Lee YP, Wang YF, Wang JR, Liu CC, Lei HY, Yu CK. 2007. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J. Virol. 81:8996&#x2013;9003. 10.1128/JVI.00236-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00236-07</ArticleId><ArticleId IdType="pmc">PMC1951457</ArticleId><ArticleId IdType="pubmed">17567704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KT, Munisamy B, Ong KC, Kojima H, Noriyo N, Chua KB, Ong BB, Nagashima K. 2008. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J. Neuropathol. Exp. Neurol. 67:162&#x2013;169. 10.1097/nen.0b013e318163a990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e318163a990</ArticleId><ArticleId IdType="pubmed">18219253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R, Racaniello VR. 1992. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 166:747&#x2013;752. 10.1093/infdis/166.4.747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/166.4.747</ArticleId><ArticleId IdType="pubmed">1326581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13:1173&#x2013;1175. 10.1038/nm1651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1651</ArticleId><ArticleId IdType="pmc">PMC5114125</ArticleId><ArticleId IdType="pubmed">17828272</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L-Y, Huang Y-C, Lin T-Y. 1998. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet 352:367&#x2013;368. 10.1016/S0140-6736(98)24031-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)24031-1</ArticleId><ArticleId IdType="pubmed">9717926</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-M, Liu C-C, Tseng H-W, Wang J-R, Huang C-C, Chen Y-J, Yang Y-J, Lin S-J, Yeh T-F. 1999. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29:184&#x2013;190. 10.1086/520149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520149</ArticleId><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, Shih SR, Ning HC, Hwang MS, Wang HS, Lee CY. 1999. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354:1682&#x2013;1686. 10.1016/S0140-6736(99)04434-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker AB. 1957. Poliomyelitis. 16. A study of pulmonary edema. Neurology 7:743&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pubmed">13483830</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiu JH, Zhu H, Xu YF, Liu JN, Xia XZ, Zhang LF. 2013. Necrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infection. Virol. J. 10:215. 10.1186/1743-422X-10-215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-215</ArticleId><ArticleId IdType="pmc">PMC3710232</ArticleId><ArticleId IdType="pubmed">23809248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjerrulf M, Grdic D, Ekman L, Schon K, Vajdy M, Lycke NY. 1997. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Immunology 92:60&#x2013;68. 10.1046/j.1365-2567.1997.00312.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2567.1997.00312.x</ArticleId><ArticleId IdType="pmc">PMC1363982</ArticleId><ArticleId IdType="pubmed">9370925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Z, Wang C, Zepp J, Wu L, Sun K, Zhao J, Chandrasekharan U, Dicorleto PE, Trapp BD, Ransohoff RM, Li X. 2013. Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells. Nat. Neurosci. 16:1401&#x2013;1408. 10.1038/nn.3505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3505</ArticleId><ArticleId IdType="pmc">PMC4106025</ArticleId><ArticleId IdType="pubmed">23995070</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter CA. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5:521&#x2013;531. 10.1038/nri1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1648</ArticleId><ArticleId IdType="pubmed">15999093</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen GC. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255&#x2013;281. 10.1146/annurev.micro.55.1.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.55.1.255</ArticleId><ArticleId IdType="pubmed">11544356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigley NJ. 2014. Complexity of interferon-gamma interactions with HSV-1. Front. Immunol. 5:15. 10.3389/fimmu.2014.00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00015</ArticleId><ArticleId IdType="pmc">PMC3915238</ArticleId><ArticleId IdType="pubmed">24567732</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturge CR, Yarovinsky F. 2014. Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infection. Infect. Immun. 82:3090&#x2013;3097. 10.1128/IAI.01722-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.01722-14</ArticleId><ArticleId IdType="pmc">PMC4136216</ArticleId><ArticleId IdType="pubmed">24866795</ArticleId></ArticleIdList></Reference><Reference><Citation>Leist TP, Eppler M, Zinkernagel RM. 1989. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J. Virol. 63:2813&#x2013;2819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC250786</ArticleId><ArticleId IdType="pubmed">2542591</ArticleId></ArticleIdList></Reference><Reference><Citation>Klavinskis LS, Geckeler R, Oldstone MB. 1989. Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo. J. Gen. Virol. 70(Part 12):3317&#x2013;3325. 10.1099/0022-1317-70-12-3317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-70-12-3317</ArticleId><ArticleId IdType="pubmed">2514255</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918&#x2013;1921. 10.1126/science.8009221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8009221</ArticleId><ArticleId IdType="pubmed">8009221</ArticleId></ArticleIdList></Reference><Reference><Citation>Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E. 2004. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J. Virol. 78:2701&#x2013;2710. 10.1128/JVI.78.6.2701-2710.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.6.2701-2710.2004</ArticleId><ArticleId IdType="pmc">PMC353772</ArticleId><ArticleId IdType="pubmed">14990690</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesler DA, Reiss CS. 2002. The role of IFN-&#x3b3; in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev. 13:441&#x2013;454. 10.1016/S1359-6101(02)00044-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1359-6101(02)00044-8</ArticleId><ArticleId IdType="pubmed">12401479</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu T, Reiss CS. 1997. IFN-&#x3b3; is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb. J. Immunol. 159:3444&#x2013;3452.</Citation><ArticleIdList><ArticleId IdType="pubmed">9317143</ArticleId></ArticleIdList></Reference><Reference><Citation>Nansen A, Christensen JP, Ropke C, Marker O, Scheynius A, Thomsen AR. 1998. Role of interferon-gamma in the pathogenesis of LCMV-induced meningitis: unimpaired leucocyte recruitment, but deficient macrophage activation in interferon-gamma knock-out mice. J. Neuroimmunol. 86:202&#x2013;212. 10.1016/S0165-5728(98)00055-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(98)00055-1</ArticleId><ArticleId IdType="pubmed">9663567</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Hix L, Sigal LJ, Andino R. 2002. Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection. J. Gen. Virol. 83:1707&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pubmed">12075090</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauder S, Kan S, Racaniello VR. 2006. Age-dependent poliovirus replication in the mouse central nervous system is determined by internal ribosome entry site-mediated translation. J. Virol. 80:2589&#x2013;2595. 10.1128/JVI.80.6.2589-2595.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.6.2589-2595.2006</ArticleId><ArticleId IdType="pmc">PMC1395422</ArticleId><ArticleId IdType="pubmed">16501069</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang AS, Baltimore D. 1970. Defective viral particles and viral disease processes. Nature 226:325&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">5439728</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>